Nicholas Donoghoe - 20 Mar 2024 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role: EVP, CHIEF BUS/STRAT OFFICER
Signature: T.O. Odutayo, attorney-in-fact for Nicholas J. Donoghoe
Issuer symbol: ABBV
Transactions as of: 20 Mar 2024
Transactions value $: -$3,716,757
Form type: 4
Filing time: 22 Mar 2024, 17:00:15 UTC
Previous filing: 01 Mar 2024
Next filing: 18 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABBV	Common Stock, $0.01 par value	Sale	-$3.72M	-21.1K	-27.38%	$176.30	55.9K	20 Mar 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.26 to $176.35, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.26 to $176.35, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.